The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition.

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms / L. Arcaini, S. Zibellini, E. Boveri, R. Riboni, S. Rattotti, M. Varettoni, M.L. Guerrera, M. Lucioni, A. Tenore, M. Merli, S. Rizzi, L. Morello, C. Cavalloni, M.C. Da Via, M. Paulli, M. Cazzola. - In: BLOOD. - ISSN 0006-4971. - 119:1(2012 Jan), pp. 188-191. [10.1182/blood-2011-08-368209]

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms

M.C. Da Via;
2012

Abstract

The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition.
Settore MED/15 - Malattie del Sangue
gen-2012
9-nov-2011
Article (author)
File in questo prodotto:
File Dimensione Formato  
zh800112000188.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 220.33 kB
Formato Adobe PDF
220.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/950762
Citazioni
  • ???jsp.display-item.citation.pmc??? 51
  • Scopus 149
  • ???jsp.display-item.citation.isi??? 125
social impact